LESAKA TECHNOLOGIES INC (LSAK) Fundamental Analysis & Valuation

NASDAQ:LSAK • US64107N2062

Current stock price

4.99 USD
0 (0%)
Last:

This LSAK fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. LSAK Profitability Analysis

1.1 Basic Checks

  • LSAK had negative earnings in the past year.
  • In the past year LSAK had a positive cash flow from operations.
  • In the past 5 years LSAK always reported negative net income.
  • The reported operating cash flow has been mixed in the past 5 years: LSAK reported negative operating cash flow in multiple years.
LSAK Yearly Net Income VS EBIT VS OCF VS FCFLSAK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M -200M -300M

1.2 Ratios

  • LSAK has a worse Return On Assets (-7.08%) than 82.00% of its industry peers.
  • The Return On Equity of LSAK (-27.61%) is worse than 79.00% of its industry peers.
  • LSAK has a Return On Invested Capital of 1.15%. This is comparable to the rest of the industry: LSAK outperforms 41.00% of its industry peers.
Industry RankSector Rank
ROA -7.08%
ROE -27.61%
ROIC 1.15%
ROA(3y)-7.46%
ROA(5y)-7.58%
ROE(3y)-26.7%
ROE(5y)-22.49%
ROIC(3y)N/A
ROIC(5y)N/A
LSAK Yearly ROA, ROE, ROICLSAK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -20 -40 -60 -80

1.3 Margins

  • LSAK has a Operating Margin of 1.10%. This is in the lower half of the industry: LSAK underperforms 69.00% of its industry peers.
  • With a Gross Margin value of 28.16%, LSAK perfoms like the industry average, outperforming 51.00% of the companies in the same industry.
  • LSAK's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 1.1%
PM (TTM) N/A
GM 28.16%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.47%
GM growth 5Y-2.05%
LSAK Yearly Profit, Operating, Gross MarginsLSAK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50 -100 -150

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. LSAK Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so LSAK is destroying value.
  • Compared to 1 year ago, LSAK has more shares outstanding
  • Compared to 5 years ago, LSAK has more shares outstanding
  • LSAK has a worse debt/assets ratio than last year.
LSAK Yearly Shares OutstandingLSAK Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M
LSAK Yearly Total Debt VS Total AssetsLSAK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B

2.2 Solvency

  • LSAK has an Altman-Z score of 2.14. This is not the best score and indicates that LSAK is in the grey zone with still only limited risk for bankruptcy at the moment.
  • LSAK has a better Altman-Z score (2.14) than 79.00% of its industry peers.
  • LSAK has a Debt/Equity ratio of 1.25. This is a high value indicating a heavy dependency on external financing.
  • LSAK's Debt to Equity ratio of 1.25 is in line compared to the rest of the industry. LSAK outperforms 41.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.25
Debt/FCF N/A
Altman-Z 2.14
ROIC/WACC0.09
WACC12.28%
LSAK Yearly LT Debt VS Equity VS FCFLSAK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M

2.3 Liquidity

  • A Current Ratio of 1.57 indicates that LSAK should not have too much problems paying its short term obligations.
  • With a decent Current ratio value of 1.57, LSAK is doing good in the industry, outperforming 70.00% of the companies in the same industry.
  • A Quick Ratio of 1.43 indicates that LSAK should not have too much problems paying its short term obligations.
  • LSAK has a Quick ratio of 1.43. This is in the better half of the industry: LSAK outperforms 69.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.57
Quick Ratio 1.43
LSAK Yearly Current Assets VS Current LiabilitesLSAK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. LSAK Growth Analysis

3.1 Past

  • LSAK shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 41.05%, which is quite impressive.
  • LSAK shows a strong growth in Revenue. In the last year, the Revenue has grown by 24.44%.
  • LSAK shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 35.52% yearly.
EPS 1Y (TTM)41.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-60%
Revenue 1Y (TTM)24.44%
Revenue growth 3Y43.64%
Revenue growth 5Y35.52%
Sales Q2Q%21.74%

3.2 Future

  • LSAK is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 52.26% yearly.
  • Based on estimates for the next years, LSAK will show a quite strong growth in Revenue. The Revenue will grow by 19.87% on average per year.
EPS Next Y248.62%
EPS Next 2Y134.09%
EPS Next 3Y52.26%
EPS Next 5YN/A
Revenue Next Year32.3%
Revenue Next 2Y19.87%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
LSAK Yearly Revenue VS EstimatesLSAK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M
LSAK Yearly EPS VS EstimatesLSAK Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2021 2022 2023 2024 2025 2026 2027 2028 0 1 -1 2 -2 -3

More info and screens

Find the best growth stocksShow best growing peers

4

4. LSAK Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for LSAK. In the last year negative earnings were reported.
  • Based on the Price/Forward Earnings ratio of 11.95, the valuation of LSAK can be described as reasonable.
  • The rest of the industry has a similar Price/Forward Earnings ratio as LSAK.
  • LSAK's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 23.54.
Industry RankSector Rank
PE N/A
Fwd PE 11.95
LSAK Price Earnings VS Forward Price EarningsLSAK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40

4.2 Price Multiples

  • 66.00% of the companies in the same industry are more expensive than LSAK, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 10.56
LSAK Per share dataLSAK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

  • LSAK's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • LSAK's earnings are expected to grow with 52.26% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y134.09%
EPS Next 3Y52.26%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. LSAK Dividend Analysis

5.1 Amount

  • No dividends for LSAK!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

LSAK Fundamentals: All Metrics, Ratios and Statistics

LESAKA TECHNOLOGIES INC

NASDAQ:LSAK (4/10/2026, 8:00:01 PM)

4.99

0 (0%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)02-04
Earnings (Next)05-06
Inst Owners40.97%
Inst Owner Change0%
Ins Owners5.2%
Ins Owner Change25.21%
Market Cap418.76M
Revenue(TTM)717.52M
Net Income(TTM)-49.86M
Analysts82.86
Price Target8.16 (63.53%)
Short Float %0.41%
Short Ratio3.19
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)16.67%
Min EPS beat(2)-145.1%
Max EPS beat(2)178.43%
EPS beat(4)1
Avg EPS beat(4)-96.81%
Min EPS beat(4)-222.55%
Max EPS beat(4)178.43%
EPS beat(8)2
Avg EPS beat(8)-48.45%
EPS beat(12)2
Avg EPS beat(12)-44.14%
EPS beat(16)4
Avg EPS beat(16)-49.98%
Revenue beat(2)2
Avg Revenue beat(2)5.97%
Min Revenue beat(2)5.56%
Max Revenue beat(2)6.38%
Revenue beat(4)4
Avg Revenue beat(4)21.91%
Min Revenue beat(4)2.32%
Max Revenue beat(4)73.38%
Revenue beat(8)5
Avg Revenue beat(8)10.97%
Revenue beat(12)6
Avg Revenue beat(12)6.39%
Revenue beat(16)10
Avg Revenue beat(16)13.13%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-50%
EPS NY rev (1m)0%
EPS NY rev (3m)18.82%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.13%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 11.95
P/S 0.58
P/FCF N/A
P/OCF 191.48
P/B 2.32
P/tB N/A
EV/EBITDA 10.56
EPS(TTM)-0.11
EYN/A
EPS(NY)0.42
Fwd EY8.37%
FCF(TTM)-0.22
FCFYN/A
OCF(TTM)0.03
OCFY0.52%
SpS8.55
BVpS2.15
TBVpS-1.94
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -7.08%
ROE -27.61%
ROCE 1.51%
ROIC 1.15%
ROICexc 1.32%
ROICexgc 4.77%
OM 1.1%
PM (TTM) N/A
GM 28.16%
FCFM N/A
ROA(3y)-7.46%
ROA(5y)-7.58%
ROE(3y)-26.7%
ROE(5y)-22.49%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.47%
GM growth 5Y-2.05%
F-Score6
Asset Turnover1.02
Health
Industry RankSector Rank
Debt/Equity 1.25
Debt/FCF N/A
Debt/EBITDA 4.2
Cap/Depr 44.36%
Cap/Sales 2.82%
Interest Coverage 0.35
Cash Conversion 4.08%
Profit Quality N/A
Current Ratio 1.57
Quick Ratio 1.43
Altman-Z 2.14
F-Score6
WACC12.28%
ROIC/WACC0.09
Cap/Depr(3y)62.46%
Cap/Depr(5y)69.58%
Cap/Sales(3y)2.88%
Cap/Sales(5y)2.8%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)41.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-60%
EPS Next Y248.62%
EPS Next 2Y134.09%
EPS Next 3Y52.26%
EPS Next 5YN/A
Revenue 1Y (TTM)24.44%
Revenue growth 3Y43.64%
Revenue growth 5Y35.52%
Sales Q2Q%21.74%
Revenue Next Year32.3%
Revenue Next 2Y19.87%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y36.84%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year2864.24%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-290.26%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-74.44%
OCF growth 3YN/A
OCF growth 5YN/A

LESAKA TECHNOLOGIES INC / LSAK Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for LESAKA TECHNOLOGIES INC?

ChartMill assigns a fundamental rating of 3 / 10 to LSAK.


What is the valuation status for LSAK stock?

ChartMill assigns a valuation rating of 4 / 10 to LESAKA TECHNOLOGIES INC (LSAK). This can be considered as Fairly Valued.


Can you provide the profitability details for LESAKA TECHNOLOGIES INC?

LESAKA TECHNOLOGIES INC (LSAK) has a profitability rating of 1 / 10.


Can you provide the financial health for LSAK stock?

The financial health rating of LESAKA TECHNOLOGIES INC (LSAK) is 3 / 10.